Skip to content

ICU Medical

US · ICUI #2287 by market cap Listed 1970
172.52 -3.24 -1.84%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
  • Total institutional ownership (as a % of shares) was little changed.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
105.54% +0.05pp
Institutions
360 +12
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund91.34%
Public Company5.86%
Hedge Fund5.19%
Individual/Insider1.77%
Government Pension Fund1.68%
Sovereign Wealth Fund0.71%
Private Company0.29%
Insurance Company0.26%
Family Office/Trust0.16%

Top holders as of 2026-09-30

BlackRock 14.96% · 3.74M sh
Janus Henderson Group plc 11.12% · 2.78M sh
Vanguard Portfolio Management, LLC 5.86% · 1.47M sh
Fuller & Thaler Asset Management, Inc. 5.19% · 1.30M sh
Vanguard Capital Management, LLC 4.49% · 1.12M sh
Dimensional Fund Advisors 4.38% · 1.10M sh
State Street Global Advisors 4.09% · 1.02M sh
Schroder Investment Management North America LLC 2.88% · 720.64K sh
Schroder Investment Management North America Inc. 2.88% · 720.64K sh
Columbia Management Investment Advisers, LLC 2.76% · 689.57K sh
Geode Capital Management, LLC 2.63% · 656.98K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 24 buys · 26 sells

NameRoleStake
Vivek Jain Chairperson & CEO 1.12%
Brian Bonnell Chief Financial Officer 0.22%
Christian Voigtlander Chief Operating Officer 0.15%
Daniel Woolson President 0.07%
Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer 0.06%
David Greenberg Lead Independent Director 0.04%
Donald Abbey Independent Director 0.02%
David Hoffmeister Independent Director 0.02%
Elisha Finney Independent Director 0.02%
Laurie Hernandez Independent Director 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-12 Elisha Finney Independent Director Derivative Exercise and Sale -1,765 $158.20–179.00
2026-11-12 Elisha Finney Independent Director Intent to Sell (Form 144) -1,700 $179.00
2026-09-02 Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer Automatic Disposition -4,856 $167.67–171.52
2026-08-31 Brian Bonnell Chief Financial Officer Automatic Disposition -6,381 $175.00
2026-08-30 Brian Bonnell Chief Financial Officer Automatic Disposition -9,307 $171.05–173.91
2026-08-12 Daniel Woolson President Open Market Disposition -5,417 $181.33
2026-08-11 Ben Sousa Chief Information Officer Open Market Disposition -2,250 $178.32
2026-08-10 Elisha Finney Independent Director Open Market Disposition -378 $182.48
2026-08-10 Christian Voigtlander Chief Operating Officer Open Market Disposition -8,929 $182.93
2026-05-21 Daniel Woolson President Open Market Disposition -2,123 $132.21
2026-05-13 Virginia Sanzone Corporate VP, General Counsel, Secretary & Compliance Officer Open Market Disposition -2,447 $124.08
2026-05-12 Elisha Finney Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Elisha Finney Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 Kolleen Kennedy Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Kolleen Kennedy Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 David Hoffmeister Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 David Hoffmeister Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 Laurie Hernandez Independent Director Other Derivative Acquisition +1,475 --
2026-05-12 Laurie Hernandez Independent Director Derivative Exercise and Retained +1,254 --
2026-05-12 David Greenberg Lead Independent Director Other Derivative Acquisition +1,475 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

ICU Medical discussion 0 comments

Add a comment